Open original FDA record ↗Recall record
- FDA identifier
- Z-1941-2024
- Company in FDA record
- Stryker Neurovascular
- FDA classification date
- May 31, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
Source facts
- Action
- On 4/29/24, recall notices were mailed to Supply Chain Management/ Recall Coordinator/ Inventory Manager customers who were asked to do the following: 1) When using impacted guidewires, please do not backload the guidewire, follow the Instructions for Use (IFU) provided with the device, and do not use the guidewire if you see any visible signs of coating damage. 2) Circulate this customer notification internally to all interested/affected parties. 3) Inform firm if any of the subject devices have been distributed to other organizations. If yes, provide contact details so that the firm can inform the recipients appropriately. 4) Inform firm of any adverse events concerning the use of the subject devices. (US Customer Service: 1-855-91-NEURO (1-855-916-3876), Email: NVCustomerCare@stryker.com) 5) Complete and return the customer response form via email to: nvfieldactions@stryker.com. 6) Contact the firm if you would like a replacement of the guidewire with a new optional introducer accessory.
- Initiated
- 2024-04-18
- Root cause
- Component design/selection
- Distribution
- Worldwide - US Nationwide distribution including in the states of TX, NY, MD, CA, KY, WI, OR, NE, SC, MA, MO, CT, ID, PA, TN, FL, NC, AL, IA, OK, VA, IL, OH, NH, MN, ND, KS, NJ, WV, IN, GA, HI, AR, UT, LA, MI, WA, NV, CO, AZ, DC, VT, ME, DE, AK, WY, MT, NM, SD, MS, RI, GU and the countries of ARGENTINA, AUSTRALIA, AUSTRIA, BAHRAIN, BELGIUM, BRAZIL, BULGARIA, CANADA, CHINA, COLOMBIA, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT, ESTONIA, FINLAND, FRANCE, GERMANY, GREECE, HONG KONG, HUNGARY, ICELAND, INDIA, IRAN, IRELAND, ISRAEL, ITALIA, JAPAN, JORDAN, KUWAIT, LITHUANIA, LUXEMBOURG, MEXICO, NETHERLANDS, NORTHERN IRELAND, NORWAY, PHILIPPINES, POLAND, PORTUGAL, ROMANIA, RUSSIA, SAUDI ARABIA, SINGAPORE, SLOVAKIA, SLOVENIA, SOUTH AFRICA, SOUTH KOREA, SPAIN, SWEDEN, SWITZERLAND, TAIWAN, THAILAND, TURKEY, UAE, UK.
- Recall number
- Z-1941-2024
- Recall status
- Open, Classified
- CDRH record ID
- 207544
- FDA classified
- 2024-05-31
- Recall event number
- 94543